Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01437995 · ClinicalTrials.gov registry record · Phase 4
Long-acting Beta Agonist Step Down Study
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 459
- Enrollment target
NCT01437995: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT01437995 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 459 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01437995, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 459 participants
- Enrollment target
Study Summary
This study is a 56-week, multi-center, blinded, randomized, double-masked parallel group comparative effectiveness study of approaches to stepping down therapy for patients with well-controlled asthma treated with combination ICS and LABA.
Interventions
- DRUG Fluticasone/Salmeterol Diskus
- DRUG Fluticasone Diskus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01437995
The ClinicalTrials.gov registry entry for NCT01437995 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 459 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluticasone/Salmeterol Diskus is the first listed.
NCT01437995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01437995 about?
NCT01437995 is a clinical study titled "Long-acting Beta Agonist Step Down Study". This study is a 56-week, multi-center, blinded, randomized, double-masked parallel group comparative effectiveness study of approaches to stepping down therapy for patients with well-controlled asthma treated with combination ICS and LABA.
What is the current status of trial NCT01437995?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 459 participants. The study started on 2012-03. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01437995?
The interventions under investigation include: Fluticasone/Salmeterol Diskus (DRUG), Fluticasone Diskus (DRUG).
Who is sponsoring clinical trial NCT01437995?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.